🇺🇸 FDA

P0 · Therapeutic area intelligence

Infectious disease patent intelligence

Antiviral, antibacterial, and vaccine-related pharmaceutical patents.

Patents
1,469

Quick answer

1,469 US pharmaceutical patents in our index match Infectious disease title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 6319904

    Formulation comprising antibacterial substance and antiulcer substance

    Takeda Chemical Industries Ltd. · Granted Tue Nov 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6316190

    Oligonucleotides which specifically bind retroviral nucleocapsid proteins

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6313090

    Methods for treating parasitic infection using thiopeptides

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6313178

    Use of hexahydrolupulones as antibacterial and anticancer agents

    Regents of the University of Minnesota · Granted Tue Nov 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 6309669

    Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix

    The United States of America as represented by the Secretary of the Army · Granted Tue Oct 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6305380

    Method for treatment of cancer and infectious disease

    Maxim Pharmaceuticals, Inc. · Granted Tue Oct 23 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6303334

    Nucleic acid encoding a transdominant negative retroviral integrase

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 16 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6297004

    Recombinant viruses displaying a nonviral polypeptide on their external surface

    Cambridge Drug Discovery Holding, LTD · Granted Tue Oct 02 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6294322

    Multideterminant peptides that elicit helper T-lymphocyte cytotoxic T-lymphocyte and neutralizing antibody responses against HIV-1

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 25 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6291431

    Methods and compositions for the treatment and prevention of Staphylococcal infections

    The Regents of the University of California · Granted Tue Sep 18 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6290963

    Anti-HIV compositions containing native and recombinant peptides

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 18 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6291637

    Interference with viral IRES-mediated translation by a small yeast RNA reveals critical RNA-protein interactions

    The Regents of the University of California · Granted Tue Sep 18 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6287759

    Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6274598

    Methods for treating antibiotic-resistant infections

    The United States of America as represented by the Secretary of the Army · Granted Tue Aug 14 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6274611

    Methods and compositions for inhibition of viral replication

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 14 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6268383

    Substituted aromatic compounds for treatment of antibiotic-resistant infections

    The United States of America as represented by the Secretary of the Army · Granted Tue Jul 31 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6264957

    Product of infectious respiratory syncytial virus from cloned nucleotide sequences

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 24 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6265380

    Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

    Vertex Pharmaceuticals Incorporated · Granted Tue Jul 24 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6264952

    Method for protecting a mammalian host against infection by Brucella

    The Board of Regents for Oklahoma State University · Granted Tue Jul 24 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6254867

    Human monoclonal antibodies to the hepatitis B surface antigen

    XTL BIOPHARMACEUTICALS LTD. · Granted Tue Jul 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6245362

    Medication for treatment of viral disease based on active agents of plant hypericum (St. John's Wort) and method of production of the medication

    Dreluso Pharmazeutika Dr. Elten & Sohn GmbH · Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6245737

    Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6241989

    Recombinant multivalent viral vaccine

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 05 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6235881

    Polypeptides encoded by novel HIV-2 proviruses

    The Regents of the University of California · Granted Tue May 22 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6229005

    DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 08 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6214801

    Imidazo[1,2-a]pyridine C-nucleosides as antiviral agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 10 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6214347

    Multideterminant peptides that elicit helper T-lymphocyte, cytotoxic T lymphocyte and neutralizing antibody responses against HIV-1

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 10 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6214805

    RNase L activators and antisense oligonucleotides effective to treat RSV infections

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 10 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6207416

    Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6200811

    Cell transformation vector comprising an HIV-2 packaging site nucleic acid and an HIV-1 GAG protein

    The Regents of the University of California · Granted Tue Mar 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6197578

    Cells expressing both human CD4 and a human fusion accessory factor associated with HIV infection

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6187775

    Acridone-derived compounds useful as antineoplastic and antiretroviral agents

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6180110

    Attenuated hepatitis a virus vaccine which grows in MRC-5 cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6171596

    Oligomeric HIV-1 envelope glycoproteins

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6165484

    EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections

    The Board of Regents of the University of Texas System · Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6159936

    Compositions and methods for treating and preventing microbial and viral infections

    The Regents of the University of California · Granted Tue Dec 12 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6159684

    HIV trans-activator TAT binding to CDK7 and activation of CTD phosphorylation

    The Regents of the University of California · Granted Tue Dec 12 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6155266

    Method for treatment of cancer and infectious disease

    Maxim Pharmaceuticals, Inc. · Granted Tue Dec 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6156541

    Compositions and methods for catalyzing hydrolysis of HIV gp120

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Dec 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6153589

    2,3-epoxy alcohols, acids and derivatives as anti retroviral chemotherapeutic agents

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 28 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6153421

    Cloned genomes of infectious hepatitis C viruses and uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 28 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6146629

    Human monoclonal antibody against Hepatitis B virus surface antigen (HBVsAg)

    XTL BIOPHARMACEUTICALS LTD. · Granted Tue Nov 14 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6146643

    Human/simian chimeric hepatitis A virus vaccine

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 14 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6132962

    Retroviral vectors comprising an anti-hiv or other nucleic acid

    The Regents of the University of California · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6124271

    Method and conjugate for treating H. pylori infection

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Sep 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6120988

    Method of detecting hev infection

    The United States of America · Granted Tue Sep 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6113905

    Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases

    The Regents of the University of California · Granted Tue Sep 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6113912

    Hepatitis A virus vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many Infectious disease patents are indexed?

1,469 patents match our Infectious disease classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.